VC
Vivo Capital Portfolio holdings
AUM
$977M
1-Year Return
209.68%
This Quarter Return
-0.55%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$1.73B
AUM Growth
+$336M
(+24%)
Cap. Flow
+$415M
Cap. Flow
% of AUM
23.97%
Top 10 Holdings %
Top 10 Hldgs %
59.34%
Holding
67
New
13
Increased
7
Reduced
17
Closed
3
Top Buys
| 1 |
ALX Oncology
ALXO
|
+$159M |
| 2 |
Harmony Biosciences
HRMY
|
+$154M |
| 3 |
Novavax
NVAX
|
+$17.8M |
| 4 |
Nkarta
NKTX
|
+$15.4M |
| 5 |
Cytokinetics
CYTK
|
+$15.2M |
Top Sells
| 1 |
Verastem
VSTM
|
+$7.98M |
| 2 |
Legend Biotech
LEGN
|
+$6.94M |
| 3 |
Arcutis Biotherapeutics
ARQT
|
+$5.16M |
| 4 |
Zymeworks
ZYME
|
+$4.37M |
| 5 |
Galmed Pharmaceuticals
GLMD
|
+$4.11M |
Sector Composition
| 1 | Healthcare | 91.47% |
| 2 | Financials | 6.31% |
| 3 | Materials | 2.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVDL
26
Avadel Pharmaceuticals
AVDL
$1.5B
| $17.8M | 1.03% |
3,526,093
| – | – |
|
27
Kiniksa Pharmaceuticals
KNSA
$2.75B
| $17.6M | 1.02% |
1,151,622
| – | – |
|
28
Akero Therapeutics
AKRO
$3.48B
| $17.6M | 1.02% |
571,833
-19,336
| -3% | -$595K |
|
29
Codexis
CDXS
$219M
| $17.3M | 1% |
1,476,289
-17,614
| -1% | -$207K |
|
|
MREO
30
Mereo BioPharma
MREO
$294M
| $16.3M | 0.94% |
6,220,938
+5,442,938
| +700% | +$14.3M |
|
|
31
Nkarta
NKTX
$140M
| $15.4M | 0.89% |
+512,225
| New | +$15.4M |
|
|
32
Cytokinetics
CYTK
$6.12B
| $15.2M | 0.88% |
+700,000
| New | +$15.2M |
|
|
CBAY
33
DELISTED
Cymabay Therapeutics
CBAY
| $15.1M | 0.87% |
2,089,356
| – | – |
|
|
ZGNX
34
DELISTED
Zogenix, Inc.
ZGNX
| $14.7M | 0.85% |
817,935
+159,412
| +24% | +$2.86M |
|
|
EIGR
35
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $14.6M | 0.84% |
59,709
| – | – |
|
|
CALT
36
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
| $13.9M | 0.8% |
580,000
| – | – |
|
|
KDNY
37
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $12.4M | 0.72% |
1,023,712
| – | – |
|
38
Larimar Therapeutics
LRMR
$336M
| $12.1M | 0.7% |
799,662
| – | – |
|
39
ESSA Pharma
EPIX
$9.6M
| $10.5M | 0.6% |
+1,516,865
| New | +$10.5M |
|
40
Zai Lab
ZLAB
$3.65B
| $10.2M | 0.59% |
122,107
| – | – |
|
41
Q32 Bio
QTTB
$23.5M
| $9.13M | 0.53% |
47,397
-1,253
| -3% | -$241K |
|
42
Matinas BioPharma
MTNB
$10.2M
| $8.64M | 0.5% |
225,586
| – | – |
|
|
PSTX
43
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $8.22M | 0.47% |
+926,449
| New | +$8.22M |
|
44
CureVac
CVAC
$1.2B
| $7.91M | 0.46% |
+169,825
| New | +$7.91M |
|
|
IGMS
45
DELISTED
IGM Biosciences
IGMS
| $7.64M | 0.44% |
103,480
-16,000
| -13% | -$1.18M |
|
46
Aurinia Pharmaceuticals
AUPH
$1.68B
| $7.38M | 0.43% |
500,732
| – | – |
|
47
Ovid Therapeutics
OVID
$89.6M
| $7.18M | 0.41% |
+1,250,000
| New | +$7.18M |
|
48
Dyne Therapeutics
DYN
$1.87B
| $6.36M | 0.37% |
+315,000
| New | +$6.36M |
|
49
KALA BIO
KALA
$131M
| $5.9M | 0.34% |
15,753
| – | – |
|
50
Athira Pharma
ATHA
$14.2M
| $5.54M | 0.32% |
+300,000
| New | +$5.54M |
|